It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Wow! Celgene Corporation Message board - Online Community of active, educated investors researching and discussing Celgene Corporation Stocks. View the latest activity on Creative Medical Technology Holdings, Inc. Stock Message Board, Live Chat Room, Stock Poll, CELZ Chart, Recent News, Trends, and More Will be well. jake66 Last visit Follow Following Unfollow. Chief Scientific. looking st the 3month chart. Welcome! Free forex prices, toplists, indices and lots more. ....In this tweet CELZ now owns multiple domains, 1.20% insider ownership o.oo % short interest. The filed patent describes a similar approach to those used in liver failure, with the exception that instead of using hepatocytes outside of the body, the device uses AmnioStemTM amniotic fluid derived stem cells. Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. is a commercial-stage biotechnology company focused on Urology and Neurology using stem cell treatments. Through this patent, we are aiming to recapitulate this effect, in an ethical and technically feasible manner." Creative Medical Technology Holdings announced today filing of patent application number 62663912 covering the use of its AmnioStemTM stem cells as a means of reducing/reversing natural aging. Phoenix, Arizona--(Newsfile Corp. - June 17, 2020) - Creative Medical Technology Holdings, Inc. (OTC PINK: CELZ), a leading commercial stage regenerative medicine company focused on Urology, Orthopedics and Neurology using adult stem cell treatments, today announced business updates and plans for … Market Activity. CELZ Long. ... Creative Medical Technology Holdings Recruits Internationally Renowned Kidney Expert to Scientific Advisory Board: Feb 1: ... Add Stock To Watchlist. All rights reserved. Ameritrade , Trading Software from E Signal . These are all patients for which pharmacological interventions such as Viagra and Cialis do not work," said Dr. Alexander Gershman. Get Creative Medical Technology Holdings, Inc.'s stock price today. CELZ Stock Message Board for Investors. CELZ stock rating and analysis - Creative Medical Technology Holdings Inc : a summary of key financial strength and profitability metrics. Amniotic fluid is typically considered medical waste. As a treating physician I have experienced first hand the safety and efficacy of the CaverStemTM procedure and I'm excited to introduce our technology to my peers in the international urology community. Creative Medical Technology Holdings Inc Stock Price, News and Company Updates. Company Name: Celsius Holdings Inc, Stock Symbol: CELH, Total Posts: 8478, Last Post: 2/23/2021 9:44:09 AM The concept of using cells that are growing outside of the body as a means of modifying physiological activities has previously been performed and appears feasible. Closing Summary. Said Dr. Thomas Ichim, the Company's Chief Scientific Officer. © (PK) (CELZ) stock price, charts, trades & the US's most popular discussion forums. The, That was for another procedure but I wanted, Here you go j...: https://translational-medicine.biomedcentral.com/articles/10.1, The 80% success rate is from company owner, So this is a lie docsetc? Long. The Reverse Stock Split will become effective pursuant a Certificate of Amendment (the “Certificate”) filed by the Company with the Secretary of State of the State of Nevada on January 28, 2020 pursuant to Nevada Revised Statutes (“NRS”) Sections 78.385 and 78.390. Learn how to trade big board and penny stocks by learning to read stock charts and identify technical patterns through technical analysis. CELZ 0.05 0.01 (16.07%). Dr. Alexander Gershman, an internationally renowned urologist, lecturer, inventor and Scientific Advisory Board Member at Creative Medical Technology Holdings, Inc., will take on an expanded role with CaverStem International, utilizing not only his vast expertise but also his international relationships in the urology community to expand our physician base. CELZ - Creative Medical Technology Holdings, Inc. About. As previously reported, the Board of Directors and stockholders of Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), have approved a reverse stock split of the Company’s common stock, par value $0.001 per share (the “Common Stock”),at a ratio of 1-for-150 (the “Reverse Stock Split”). Broker Dealer Data. CELZ Stock Chart. "At Creative Medical Technology Holdings we are committed to advancing regenerative medicine to various areas of human suffering. This process differs significantly from our other technologies whereupon we use the patients own bone marrow derived stem cells. Investors Hangout. General corporate updates and plans for second half of 2019. These stem cells have been published to be capable of treating animal models of numerous diseases including stroke5, heart attack6, liver failure7, colitis8, diabetes9, emphysema10, and kidney injury11. $hhse no, All I have to say is...get that needle away from, Wrong.....0085 close today....10Q Out. I am enthusiastic about the approach being developed by Creative Medical Technology Holdings, which overcomes some of the important roadblocks that prevent implementation of this novel and promising approach," said Amit Patel, MD, MS, Chief of Cardiothoracic Surgery University of Miami and coinventor of the patent. Let’s bust through .10s, Looking good here. Our team consists of leading international researchers in regenerative medicine. Creative Medical Technology Holdings Inc (CELZ) Message Board. 23/02/2021 04:09:00 1 … We are, https://investorshangout.com/images/MYImages/1866, Holding BIGLY here brother! A copy of the Certificate has been filed as Exhibit 3.1 hereto and is incorporated herein by reference.". Reuters , Fidelity , The Street , Yahoo! Safe &, $CELZ........ A real PHD: Thomas Ichim PhD Specifically, similar approaches to mixing patient blood with cells outside of the body have previously been attempted in the area of liver failure. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Hidden gem just like, 27.12% v24,913,626 c.01500 f830,514,430 it hit, The latest report, Digital Thermometer market. January 4, 2021 -- InvestorsHub NewsWire -- via By Alex Carlson -- The last half of 2020 was a banner year for penny stock investors. 13/01/2021 10:41:17 1-888-992-3836 Free Membership Login Home Homepage Membership Levels General Discussion Complete Stock List Value Investing Forum Value Conference The book Podcast Membership Data Coverage Founder's Message Free Trial 1,228 likes. A clinical trial demonstrated feasibility of using cell culture of hepatocytes to act as a "liver assist device". Specifically, similar approaches to mixing patient blood with cells outside of the body have previously been attempted in the area of liver failure. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. "What is stunning about the AmnioStemTM stem cell, which was licensed by the Company from the University of California San Diego, is that it possesses many regenerative features but is collected from non-controversial sources.". These devices are currently in Phase 3 of clinical trials1,2. https://www.otcmarkets.com/stock/CELZ/news/Creative-Medical-Technology-Holdings-Files-Patent-on-Anti-aging-Technology-Using-AmnioStem-Stem-Cells?id=191516. Overall Average: 100% Buy. 2021 If this were to get even a fraction of the investor research and message board traffic outside of Yahoo.....this would take off. ', "Our goal is to continue to internally develop and patent technology in the regenerative medicine space and to broaden our patent portfolio for future commercialization by the company and/or with other life science companies with complementary technology." Currently the company continues to focus its efforts on commercialization of its lead out technologies CaverStem® and FemCelz™. StockGuild Last visit Follow Following Unfollow. jake66. View CELZ's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Wait for that, Big mistake.....will see .07 +.....you just got, Glad I left this turd in the 3s. Investors Hangout is an all free stock message board website with over 40,000 stock boards fully equipped with a chart and stock quotes! The disclaimer is to be read and fully understood before using our site, joining our email list, or viewing any releases that pennystockdream.com releases via any medium. CELZ stock quote, chart and news. The AmnioStemTM stem cell is derived from amniotic fluid during the process of amniocentesis. Message Board Total Posts: 320 Market Activity. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. "I am pleased to take on this expanded role as a Manager and Member of CaverStem International. Creative Medical Technol... (PK) (CELZ) stock price, charts, trades & the US's most popular discussion forums. NASDAQ and other data delayed 15 minutes unless indicated. CELZ | Complete Creative Medical Technology Holdings Inc. stock news by MarketWatch. IQ. looking like this is the last support channel we have. Scientists at University of California San Diego have developed means of extracting and growing stem cells from the amniotic fluid. For more information on the procedure go to www.caverstem.com. This especially includes online social networking sources, our penny stock newsletters, stock blog, text message updates, advertisements, and the spoken word.Also note that this disclaimer is … NameNotImportant predicted that CELZ for 2019-05-06 is going $0.0080 (-89.03%) 2 years ago Laman predicted that CELZ for 2018-07-17 is going $0.0700 (-3.98%) Looking for a .10 break, Did you bother to notice, this article says, unfortunately everything he said was always true. Drug free © 2021 Copyright Investors Hangout, LLC All Rights Reserved. CELZ, 1D. Creative Medical Technology Holdings Corporate Update. Through our own research and collaborations with leading academic institutions, CMTH has, Creative Medical Technology Holdings Files Patent on Anti-aging Technology Using AmnioStem Stem Cells, The concept of using cells that are growing outside of the body as a means of modifying physiological activities has previously been performed and appears feasible. Approximately 30% of the 30,000,000 patients suffering from erectile dysfunction do not respond to drugs like Viagra, Cialis and Levitra, in part due to an underlying degeneration of the biological machinery needed to achieve erections. All the Debbie Downers are on the site today bashing CELZ. Through our own research and collaborations with leading academic institutions, CMTH has acquired a groundbreaking stem cell (Amniostem), developed proprietary protocols, built an extensive intellectual property portfolio, developed complete treatment offerings for erectile dysfunction, launched a 40-patient trial for ED at UCLA and are breaking new ground for treating stroke using our newly acquired amniotic fluid-based stem cell. This requires a an investigational new drug application process through the FDA, of which we are highly familiar. View the Terms of Use.NYSE/AMEX data delayed 20 minutes. Creative Medical Technology Holdings, Inc. https://www.otcmarkets.com/stock/CELZ/news/Creative-Medical-Technology-Holdings-Files-Patent-on-Anti-aging-Technology-Using-AmnioStem-Stem-Cells?id=191516, CELZ News: Amended Current Report Filing (8-k/a), CELZ News: Creative Medical files for new immcelz patent. Value stocks can continue to be … OTCIQ. meitshel Last visit Follow Following Unfollow. OTC Markets , Market Wire , Business Wire . Follow along and learn as I perform a quick stock chart technical analysis review on the Creative Medical Technology Holdings, Inc. (CELZ) chart. Creative Medical Technology Holdings Inc OTC Updated Feb 25, 2021 8:59 PM. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal. Welcome aboard my, Creative Medical Technology Holdings, Inc. April, Form 10-K CREATIVE MEDICAL TECHNOL For: Dec 31, CELZ Stock Chart Video 03-20-2019 Creative, 31.82% v21,576,354 c.01160 f830,514,430 staired, 16.13% v12,034,101 c.0108 f830,514,430 dip and, 37.08% v37,416,377 c.01220 f830,514,430 Looking, Can someone tell me the results of the patent, Finally some real volume. Submission to scientific peer-reviewed journals to showcase early clinical data, Continue to onboard new CaverStem® and FemCelz™ centers strategic locales around the world, Expand online marketing campaign to create human connection at digital scale. Current Market. I sold this before they did the RS. Previous studies by the Company have demonstrated that AmnioStemTM cells secrete factors that are capable of rejuvenating aged cells. For further information about the company go to www.creativemedicaltechnology.com. ... Board of Directors. CELZ Stock | Message Board | Creative Medical Technology ... CELZ: Creative Medical Technology Holdings Inc Stock Price ... Creative Medical Technology Holdings Inc. (CELZ) Stock ... CELZ Stock Price and Chart — OTC:CELZ — TradingView. Ideas. When you have products that don't work much, CELZ today is like Christmas morning with the, Loading more CELZ this morning. Real-time trade and investing ideas on Celsius Holdings, Inc. CELH from the largest community of traders and investors. As previously reported, the Board of Directors and stockholders of Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), have approved a reverse stock split of the Company’s common stock, par value $0.001 per share (the “Common Stock”),at a ratio of 1-for-150 (the “Reverse Stock Split”). Major shareholders can include individual investors, mutual funds, hedge funds, or … then .032 or, CELZ 159% v240M c.08055 f577M H.084 morning chop, CELZ 674% v528M c.0302 f577M H.031 had R@.0081, is this thing even still active. Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. Top authors: CELZ. These devices are currently in Phase 3 of clinical trials, Creative Medical Technology Holdings Inc. (CELZ), https://www.sec.gov/Archives/edgar/data/1187953/000110465920009235/tm206374-1_8k.htm, https://www.otcmarkets.com/stock/CELZ/overview, https://www.facebook.com/CaverStem-International-210566523142371/, https://www.facebook.com/StemSpine-1715913745191312/, https://www.facebook.com/CreativeMedicalTechnologyHoldings/, https://www.facebook.com/Urology-Updates-257851814950618/, https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001187953&owner=exclude&count=40&hidefilings=0. Free forex prices, toplists, indices and lots more. but levels, Thoughts on CELZ holding .048 S@.4? its due for a push. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). PHOENIX and LOS ANGELES, June 19, 2018 /PRNewswire/ -- Creative Medical Technology Holdings (OTCQB:CELZ) announced today the formation of CaverStem International LLC, a majority owned subsidiary focused on commercializing stem cell therapy for erectile dysfunction to international physicians and their patients. Free forex prices, toplists, indices and lots more. Finance. Hoping it holds and regains some footing. Overall Average Signal calculated from all 13 indicators. Growth stocks can be more volatile than other types of stocks. 3,776 Share your opinion and gain insight from other stock traders and investors. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. "Previous studies from Stanford University3 and Harvard University4 have shown that if the circulation of an aged mouse is connected to the circulation of a young mouse, various factors secreted by young mice induce an anti-aging/rejuvenating effects on organs/tissues of aged mice. 3 talking about this. InvestorsHub.com, Inc. Healthcare Professional (HCP) Recruitment/Training ongoing with 5 new facilities coming onboard in the last 60 days and multiple other locations presently being vetted and scheduled for training. "The concept of using young blood to stimulate regeneration in aged individuals is attracting much attention in the area of regenerative medicine. And by-the-way folks, lets now forget who just joined CELZ's scientific advisory board - and that would be Dr. Boris Reznik. We are moving forward with this program and are pleased with the progress. Still a big float. Find the latest CREATIVE MEDICAL TECH HOLDING I (CELZ) stock discussion in Yahoo Finance's forum. ___________________________________________________________________________________________________________________________________________________________________________. CELZ is definitely forward leaning and has a new PR news release every week based on so many things they are doing for the betterment of the human race. QQQ 321.48 (-0.30%) AAPL 125.86 (-0.11%) "While the field of anti-aging medicine is filled with various false hopes and hype, we are attempting to address this problem cautiously and methodologically through testing our technology for safety and efficacy. I sold a while, CELZ 56% v2,4M c.03 f18,4M H.036 S.026 its also a, CELZ 66% v6,3M c.01915 f18,4M R@.02 S.012 note, The field of bioinformatics involves large scale, Buyout for at .07 after an R/S. Financial Market Data powered by Quotemedia.com. In depth view into CELZ (Creative Medical Technology Holdings) stock including the latest price, news, dividend history, earnings information and financials. Item 5.03. Stock analysis for Creative Medical Technology Holdings Inc (CELZ:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. An important activity of amniotic fluid stem cells is that cells derived from one person can be used to treat other people, making them "universal donor" stem cells. We are currently in the commercial stage of our bone marrow based stem cell treatment for Erectile Dysfunction known as CAVERSTEM, which is being marketed both nationally, and internationally. Blog. There was no shortage of big runners with Creative Medical Technologies (OTCMKTS: CELZ), DSG Global (OTCMKTS: DSGT), IQSTEL (OTCMKTS: IQST), and Premier Products Group (OTCMKTS: PMPG) all closing 2020 strong.. … The AmnioStem technology is the use of stem cells from amniotic fluid which is considered a drug. CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. is a commercial-stage biotechnology company focused on Urology and Neurology using stem cell treatments. Our “science-first” approach to treatments ensures that all of our treatments are proven to be both safe and effective. Date Float and action history. Home Homepage Membership Levels General Discussion Complete Stock List Value Investing Forum Value Conference The book Podcast Membership Data Coverage Founder's Message Free Trial Creative Medical Health Technology Holdings is offering the Caverstem™ technology to selected physicians in the USA, which qualify according to the Company's criteria. A copy of the Certificate has been filed as Exhibit 3.1 hereto and is incorporated herein by reference." CELZ Profile. (PK) (CELZ) stock price, charts, trades & the US's most popular discussion forums. ... Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Go figure after an amazing runup in the share price. About Creative Medical Technology Holdings. Creative Medical Technology Holdings, Inc. (US:CELZ) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Investors Hangout is an all free stock message board website with over 40,000 stock boards fully equipped with a chart and stock … View real-time stock prices and stock quotes for a full financial overview. Soft launch utilizing established CaverStem® clinics proving to be effective commercial strategy, As previously announced, the StemSpine program is scheduled for a soft launch in the latter part of 2019. This irrational selling is creating, Hey, Gint1, we could be hearing back from, And you’re back haha. CELZ closed up 17.65 percent on Friday, February 19, 2021, on 30 percent of normal volume. A high-level overview of Creative Medical Technology Holdings, Inc. (CELZ) stock. Dr. Gershman is one of the Managers and Members of this subsidiary. This is my one stock i am no longer worried about. Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company currently trading on the OTCQB under the ticker symbol CELZ. "We're excited that Dr. Gershman who was the first physician to treat patients commercially with the CaverStemTM procedure, is taking on this role with the company," Timothy Warbington said further. Creative Medical Technology Holdings Inc Stock Institutional Ownership and Insider Ownership - : the historical trend of stock ownership among institutions and insiders. Company Profile. CELZ: Massive 1 for 150 Reverse Stock Split of their common shares was implemented on.... Jan 28th, 2020: As previously reported, the Board of Directors and stockholders of Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), have approved a reverse stock split of the Company’s common stock, par value $0.001 per share (the “Common Stock”), The Reverse Stock Split will become effective pursuant a Certificate of Amendment (the “Certificate”) filed by the Company with the Secretary of State of the State of Nevada on January 28, 2020 pursuant to Nevada Revised Statutes (“NRS”) Sections 78.385 and 78.390. A clinical trial demonstrated feasibility of using cell culture of hepatocytes to act as a "liver assist device". $CELZ.....Other CELZ platforms more friendly available now..... Down but definitely not out... we will have, CELZ Looking awesome. By encapsulating the cells outside of the body, so that the cells are in contact with the patient's circulation, the cells are permitted to secrete factors that may reduce aging, without having to inject the cells in the patient. Find the latest CREATIVE MEDICAL TECH HOLDING I (CELZ) stock quote, history, news and other vital information to help you with your stock trading and investing. In contrast to other conditions, aging will occur in everyone," said Timothy Warbington, President and CEO of Creative Medical Technology Holdings. Videos only. "Due to the enthusiastic response from international attendees at the American Urological Association conference held in May 2018, we've determined it is in the best interest of the company to form a subsidiary to pursue commercialization with physicians from around the world," said Timothy Warbington President and CEO of Creative Medical Technologies, Inc. and Managing Member of CaverStem International LLC. Since beginning to offer the CaverStem™ procedure in December 2017 I have treated multiple patients of which approximately 90% have reported positive improvements.